1. Home
  2. MATH vs SER Comparison

MATH vs SER Comparison

Compare MATH & SER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Metalpha Technology Holding Limited

MATH

Metalpha Technology Holding Limited

SELL

Current Price

$1.04

Market Cap

49.9M

Sector

Finance

ML Signal

SELL

Logo Serina Therapeutics Inc.

SER

Serina Therapeutics Inc.

HOLD

Current Price

$1.36

Market Cap

56.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MATH
SER
Founded
2015
2017
Country
Hong Kong
United States
Employees
N/A
N/A
Industry
Finance/Investors Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
49.9M
56.4M
IPO Year
2016
2024

Fundamental Metrics

Financial Performance
Metric
MATH
SER
Price
$1.04
$1.36
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
★ $9.50
AVG Volume (30 Days)
29.1K
★ 67.7K
Earning Date
08-06-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$3.10
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.73
$1.14
52 Week High
$3.19
$4.26

Technical Indicators

Market Signals
Indicator
MATH
SER
Relative Strength Index (RSI) 52.88 34.43
Support Level $0.93 $1.33
Resistance Level $1.13 $2.13
Average True Range (ATR) 0.09 0.30
MACD -0.00 -0.02
Stochastic Oscillator 60.26 14.18

Price Performance

Historical Comparison
MATH
SER

About MATH Metalpha Technology Holding Limited

Metalpha Technology Holding Ltd mainly operates in the trading of proprietary digital assets and derivative contracts in Hong Kong. The Company's primary business operations center on digital asset services, offered through its subsidiaries. The Company generates income mainly from executing cryptocurrency-related transactions, including providing derivative solutions to over-the-counter (OTC) clients, issuing derivative products to OTC clients, and engaging in proprietary trading activities. The Company provides crypto derivative solutions and liquidity to its clients, facilitated through its principal trading activities, enabling seamless trading of crypto derivative solutions. The Company generates revenue from Hong Kong.

About SER Serina Therapeutics Inc.

Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers. The company has one reportable segment relating to the research and development of its POZ platform. The segment derives its revenues from Grant revenue. Its main product candidate, SER-252 for advanced Parkinson's disease, is anticipated to enter clinical trials.

Share on Social Networks: